A critical advance in cancer study is emerging with the use of VHH fragments to reactivate mutated p53. This crucial malignant protector protein is frequently lost in many types of tumors, resulting uncontrolled tissue https://bookmarksurl.com/story7639724/mini-antibodies-reactivate-p53-the-potential-approach-for-tumor-treatment